The University of Turku has entered into a licensing agreement with an international pharma company related to targeting of CIP2A oncoprotein. …
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test
A recent study from Finland reports that a protein kinase called LRRK2 is hyperactive in skin samples from Parkinson’s disease patients which leads to a decrease in protein synthesis.
New agreement signed with i2020 to tackle neurological diseases
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…
Turku Bioscience research groups successful in receiving funding from The Health from Science (TERVA) Academy Programme follow-up call
The Health from Science (TERVA) Academy Programme seeks bold, new research initiatives that can solve health issues related to major public health diseases. The programme highlights the importance of scientific…
Frontiers of Science: 2012 Nobel Laureate Brian K. Kobilka
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…
Researchers Develop a Simplified Method to Modify Disease Signaling with Light
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…
CIC: Olympus VS200 Slide Scanner Demo
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…
Atomic Force Microscopy: Describing the mechanical properties of diverse materials
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…
Frontiers of Science: Reprogramming T Cells with CRISPR
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…
Frontiers of Science: Why are diseases tissue-specific? Lessons from mitochondrial diseases
University of Turku Signed a Significant Drug Development Licensing Agreement August 20, 2020 All Day The University of Turku has entered into a…